Skip to content
Altius – Lifestyle
Author:
Levicept
Levicept Announces Attendance at Cantor and Jefferies Global Healthcare Conferences
September 2, 2026
Levicept Appoints Darlene Deptula-Hicks as CFO
July 7, 2026
$20 Million Revenue and Profitability Projected Over Next 12 Months for Telehealth Tech Provider with Scalable, API-Driven Platform: VSee Health, Inc. (Nasdaq: VSEE)
June 24, 2026
Levicept to Present Data Suggesting LEVI-04 May Modify Disease in Osteoarthritis at EULAR 2026
June 3, 2026
Levicept to Present Data from Phase II study of LEVI-04 at OARSI 2026 World Congress on Osteoarthritis
April 24, 2026
$14.6 Million Revenue up 40% from 2024 for Telehealth Business Focusing on Large Integrated Health Networks in the USA: VSee Health, Inc. (Nasdaq: VSEE)
April 3, 2026
Levicept Announces The Lancet Publication of LEVI-04 Phase II Clinical Trial Results, Showing Significant Reduction in Pain and Symptoms of Osteoarthritis
March 30, 2026